These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 19945487)

  • 1. Structure and functionality in flavivirus NS-proteins: perspectives for drug design.
    Bollati M; Alvarez K; Assenberg R; Baronti C; Canard B; Cook S; Coutard B; Decroly E; de Lamballerie X; Gould EA; Grard G; Grimes JM; Hilgenfeld R; Jansson AM; Malet H; Mancini EJ; Mastrangelo E; Mattevi A; Milani M; Moureau G; Neyts J; Owens RJ; Ren J; Selisko B; Speroni S; Steuber H; Stuart DI; Unge T; Bolognesi M
    Antiviral Res; 2010 Aug; 87(2):125-48. PubMed ID: 19945487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavivirus enzymes and their inhibitors.
    Knyazhanskaya E; Morais MC; Choi KH
    Enzymes; 2021; 49():265-303. PubMed ID: 34696835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development.
    Geiss BJ; Stahla-Beek HJ; Hannah AM; Gari HH; Henderson BR; Saeedi BJ; Keenan SM
    J Biomol Screen; 2011 Sep; 16(8):852-61. PubMed ID: 21788392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies Towards Protease Inhibitors for Emerging Flaviviruses.
    Nitsche C
    Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.
    Luo D; Vasudevan SG; Lescar J
    Antiviral Res; 2015 Jun; 118():148-58. PubMed ID: 25842996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
    Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
    J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flavivirus protease as a target for drug discovery.
    Brecher M; Zhang J; Li H
    Virol Sin; 2013 Dec; 28(6):326-36. PubMed ID: 24242363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral strategies to control calicivirus infections.
    Rohayem J; Bergmann M; Gebhardt J; Gould E; Tucker P; Mattevi A; Unge T; Hilgenfeld R; Neyts J
    Antiviral Res; 2010 Aug; 87(2):162-78. PubMed ID: 20471996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional insights in flavivirus NS5 proteins gained by the structure of Ntaya virus polymerase and methyltransferase.
    Krejčová K; Krafcikova P; Klima M; Chalupska D; Chalupsky K; Zilecka E; Boura E
    Structure; 2024 Aug; 32(8):1099-1109.e3. PubMed ID: 38781970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.
    Stahla-Beek HJ; April DG; Saeedi BJ; Hannah AM; Keenan SM; Geiss BJ
    J Virol; 2012 Aug; 86(16):8730-9. PubMed ID: 22674988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics and structure/function studies of Rhabdoviridae proteins involved in replication and transcription.
    Assenberg R; Delmas O; Morin B; Graham SC; De Lamballerie X; Laubert C; Coutard B; Grimes JM; Neyts J; Owens RJ; Brandt BW; Gorbalenya A; Tucker P; Stuart DI; Canard B; Bourhy H
    Antiviral Res; 2010 Aug; 87(2):149-61. PubMed ID: 20188763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors compounds of the flavivirus replication process.
    García LL; Padilla L; Castaño JC
    Virol J; 2017 May; 14(1):95. PubMed ID: 28506240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5.
    Albentosa-González L; Jimenez de Oya N; Arias A; Clemente-Casares P; Martin-Acebes MÁ; Saiz JC; Sabariegos R; Mas A
    Viruses; 2021 May; 13(5):. PubMed ID: 34066055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavivirus polymerase as a target for drug discovery.
    Malet H; Massé N; Selisko B; Romette JL; Alvarez K; Guillemot JC; Tolou H; Yap TL; Vasudevan S; Lescar J; Canard B
    Antiviral Res; 2008 Oct; 80(1):23-35. PubMed ID: 18611413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.
    Best SM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to flavivirus drug discovery.
    Botting C; Kuhn RJ
    Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid-based inhibition of flavivirus infections.
    Stein DA; Shi PY
    Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention.
    Zmurko J; Neyts J; Dallmeier K
    Rev Med Virol; 2015 Jul; 25(4):205-23. PubMed ID: 25828437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.